I am no fan of this operation, at all. And its financials are a staggering nighmare. (imo)
- but it seems to me that they should be pumping out 'some' fairly decent amounts of flower before this summer is over.
There should be some good revenue there.
Even if the flower division is not profitable immediately - or ever - the cash flow should help keep them stumbling along until some progress is made on Satipharm and/or other products.
???
Ann: Results of Share Purchase Plan offer, page-11
Add CAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
-0.003(6.67%) |
Mkt cap ! $18.71M | |||
| Open | High | Low | Value | Volume |
| 4.5¢ | 4.7¢ | 4.2¢ | $58.17K | 1.322M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 126944 | 4.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.4¢ | 84000 | 2 |
View Market Depth
| Last trade - 15.48pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
4.2¢ |
Change
-0.003 ( 8.70 %) |
||||
| Open | High | Low | Volume | ||
| 4.7¢ | 4.7¢ | 4.2¢ | 88615 | ||
| Last updated 15.25pm 14/06/2024 ? | |||||
| CAN (ASX) Chart |